Product category:
Proteomics
News Release from: Biacore | Subject: T100
Edited by the Laboratorytalk Editorial
Team on 11 February 2005
New generation protein interaction
analysis
From a single instrument, scientists can determine affinity and rate constants, binding specificity, concentration and thermodynamic parameters
Biacore has announced the launch of Biacore T100, a new generation system for protein interaction analysis The T100 provides comprehensive information about how proteins interact with other molecules
This article was originally published on Laboratorytalk on 14 Feb 2005 at 8.00am (UK)
Related stories
New generation for protein interaction analysis
Information generated is invaluable for applications such as elucidation of disease pathways, definition of therapeutic targets, selection of drug candidates and decisions on safety
Making the most of biomolecular studies
New interactive technical support tools on CD give researchers easy access to published information on surface plasmon resonance technology
New technology for proteomics research
High performance SPR-based research system for studying biomolecular interactions has been made more powerful through the incorporation of increased capacity recovery
The unique information generated by Biacore T100 is invaluable for many applications such as elucidation of disease pathways, definition of therapeutic targets, selection of drug candidates and decisions on the safety of a protein therapeutic.
Biacore says the T100 sets the performance standard for protein interaction analysis, from research through drug discovery and development to manufacturing and QC, providing the highest quality data to support decisions that ensure productive research and development.
From a single instrument, scientists can determine affinity and rate constants, binding specificity, concentration and thermodynamic parameters.
In this way, applications as time-consuming as antibody characterisation, which could take weeks by conventional methods, can be completed in days, says Biacore.
Software wizards assist with the analysis of every interaction parameter, making the system straightforward to use and suitable for both novice and experienced users.
Initially acknowledged as essential in basic research, the unique data provided by Biacore systems are now widely used by biotechnology and pharmaceutical companies to make well-informed decisions at critical stages throughout the development and manufacture of novel therapeutics.
To fulfill stringent regulatory requirements, the T100 has been designed with a high level of in-built GLP/GMP/GCP support and 21 CFR Part 11 compliance.
An optional GxP support package will save users significant time during validation.
Erik Wallden, Biacore's president and CEO, commented: "Biacore T100 is our new flagship system, the fruit of our skills and expertise gained through 15 years of experience since we introduced real time protein interaction analysis into the life science market.
"We are confident that both existing and new Biacore users will benefit from the system's unmatched performance and ease-of-use.
"T100 offers even greater opportunities for scientists to benefit from real time protein interaction analysis wherever they work in the life sciences.".
• Biacore: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
